Dhrubjyoti Sharma

Dhrubjyoti Sharma

Auto-generated profile, based on publicly available information

Dhrubjyoti Sharma

Department of Biological Sciences and Engineering, Indian Institute of Technology Gandhinagar, Palaj, Gandhinagar, Gujarat, India, iitgn.ac.in

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2023 in Cleaner and Circular Bioeconomy
Verified
Journal Article
Open access
ANAniket Naha
Aniket Naha
RDReetika Debroy
Reetika Debroy
DSDhrubjyoti Sharma
Dhrubjyoti Sharma
MSMaulin P. Shah
Maulin P. Shah
SNSoumitra Nath
Soumitra Nath

14 February 2020 in Archives of Microbiology
Verified
Journal Article
Closed access
PDF file
ASAnbazahan Sannasimuthu
Anbazahan Sannasimuthu
DSDhrubjyoti Sharma
Dhrubjyoti Sharma
BPBilal Paray
Bilal Paray
MAMohammed K. Al-Sadoon
Mohammed K. Al-Sadoon
JAJesu Arockiaraj
Jesu Arockiaraj

1 January 2026 in Mediators of Inflammation
Verified
Journal Article
Open access
MPManali Patel
Manali Patel
HAHiral Aghara
Hiral Aghara
PCPrashsti Chadha
Prashsti Chadha
HSHarshrajsinh Solanki
Harshrajsinh Solanki
DSDhrubjyoti Sharma
Dhrubjyoti Sharma
PALASH MANDALPALASH MANDAL
PALASH MANDAL
Chronic ethanol exposure activates inflammatory signaling pathways and inflicts hepatocellular damage, leading to alcohol‐associated liver diseases (ALDs). ALD is one of the major causes of global burden, yet there are no FDA‐approved treatment options available. This study evaluates the hepatoprotective effects of short‐chain fatty acids (SCFAs), mainly sodium acetate (NaA) and sodium butyrate (NaB), against ethanol‐induced inflammation and oxidative stress in both in vitro (Buffalo Rat Liver‐3A [BRL3A]) and in vivo (male Wistar rats) models. The treatment of NaA and NaB and their combination was given to the cell lines where maximum viability was observed at concentrations of 1.5 mM, 5 mM, and 0.1 mM + 1 mM, respectively. Additionally, reactive oxygen species (ROS) and nuclear morphology were assessed by fluorescent staining. For in vivo samples, the hepatic injury was analyzed by serum biochemical markers. Furthermore, hematoxylin and eosin (H&E) staining and immunohistochemistry (IHC) staining were employed, which provided structural and immunological alterations in hepatic tissue. RT‐qPCR profiled the expression levels of various pro‐inflammatory and anti‐inflammatory cytokines, as well as cytochrome P450 E1 (CYP2E1) and antioxidative stress markers. Moreover, enzyme‐linked immunosorbent assay (ELISA) quantified the essential protein targets such as TNF‐α, MCP‐1, IL‐1β, IL‐6, HO‐1, and Nrf2. The administration of NaA, NaB, and their combination resulted in reduced ROS levels and expression of pro‐inflammatory cytokines, preserved nuclear integrity, and neutrophil infiltration. These findings were further confirmed by in silico analysis and conserved amino acid interactions, and the affinities of NaA and NaB for TNF‐α and MCP‐1 were observed as compared to established inhibitors or activators. This study is the first demonstration to report the synergistic effects of NaA and NaB on the feedback loop of the nuclear factor kappa B (NF‐κB) signaling pathway, suggesting their potential as promising therapeutic candidates for alleviating alcohol‐induced hepatic damage.